Opioid Prescribing to US Children and Young Adults in 2019
Recent national data are lacking on the prevalence, safety, and prescribers of opioid prescriptions dispensed to children and young adults aged 0 to 21 years. More
Recent national data are lacking on the prevalence, safety, and prescribers of opioid prescriptions dispensed to children and young adults aged 0 to 21 years. More
How the Food and Drug Administration messes up approval of new drugs including the new one, aducanumab, that supposedly helps Alzheimer’s disease patients. More
This is the second of two articles on reframing the debate about low-benefit treatments. More
“This drug needs to be pulled off the market — period," said Adam Uratro, the chief of maternal-fetal medicine at MetroWest Medical Center. More
In collaboration with various organizations, this blog explains a new letter released by 200+ groups urging Congress to address the maternal health crisis in our country. More
This Viewpoint highlights the effects of anti-Black racism on Black clinicians and patients, explains the difference between superficial and meaningful efforts to exert change, and itemizes meaningful actions that can assist in the effort to end systemic racism. More
As a matter of simple economics, hospital price transparency will improve competition and encourage more equitable pricing. More
og:description Medical journals are relied on as trusted sources of medical information. For years, authors’ conflicts of interest—both disclosed and undisclosed— have repeatedly undermined the credibility of the medical profession and the medical literature. More
Health care groups don't want transparency that reveals true prices. More
Companies and rich nations are creating a deadly covid-19 vaccine “protection racket” More